These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25447825)

  • 21. Impact of chirality on the Glass Forming Ability and the crystallization from the amorphous state of 5-ethyl-5-methylhydantoin, a chiral poor glass former.
    Atawa B; Couvrat N; Coquerel G; Dargent E; Saiter A
    Int J Pharm; 2018 Apr; 540(1-2):11-21. PubMed ID: 29407191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Physical Stability of Amorphous Drug Formulations via Dry Polymer Coating.
    Capece M; Davé R
    J Pharm Sci; 2015 Jun; 104(6):2076-2084. PubMed ID: 25902736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
    Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
    AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting Crystallization of Amorphous Drugs with Terahertz Spectroscopy.
    Sibik J; Löbmann K; Rades T; Zeitler JA
    Mol Pharm; 2015 Aug; 12(8):3062-8. PubMed ID: 26090554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Progress in the research of amorphous pharmaceuticals].
    Ying J; Lü Y; Du GH
    Yao Xue Xue Bao; 2009 May; 44(5):443-8. PubMed ID: 19618716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relaxation and crystallization of amorphous carbamazepine studied by terahertz pulsed spectroscopy.
    Zeitler JA; Taday PF; Pepper M; Rades T
    J Pharm Sci; 2007 Oct; 96(10):2703-9. PubMed ID: 17696163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermal analysis of paracetamol polymorphs by FT-IR spectroscopies.
    Zimmermann B; Baranović G
    J Pharm Biomed Anal; 2011 Jan; 54(2):295-302. PubMed ID: 20863645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.
    Forsgren J; Andersson M; Nilsson P; Mihranyan A
    Adv Healthc Mater; 2013 Nov; 2(11):1469-76. PubMed ID: 23703752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of a Stable Coamorphous System Using Lactose as an Antiplasticizing Agent for Diphenhydramine Hydrochloride with a Low Glass Transition Temperature.
    Ueda H; Hirakawa Y; Miyano T; Imono M; Tse JY; Uchiyama H; Tozuka Y; Kadota K
    Mol Pharm; 2022 Apr; 19(4):1209-1218. PubMed ID: 35316068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of molecular mobility on the physical stability of amorphous pharmaceuticals in the supercooled and glassy States.
    Kothari K; Ragoonanan V; Suryanarayanan R
    Mol Pharm; 2014 Sep; 11(9):3048-55. PubMed ID: 25105216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical stability of the amorphous anticholesterol agent (ezetimibe): the role of molecular mobility.
    Knapik J; Wojnarowska Z; Grzybowska K; Hawelek L; Sawicki W; Wlodarski K; Markowski J; Paluch M
    Mol Pharm; 2014 Nov; 11(11):4280-90. PubMed ID: 25310722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems.
    Kalogeras IM
    Eur J Pharm Sci; 2011 Apr; 42(5):470-83. PubMed ID: 21324354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability.
    Alhalaweh A; Alzghoul A; Mahlin D; Bergström CAS
    Int J Pharm; 2015 Nov; 495(1):312-317. PubMed ID: 26341321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]